When recommending to female clients that

they be evaluated for psychotropic medication,

several unique issues and concerns arise. 

 

Discuss

in detail these problems, and develop a strategy

of how you will address them.

 

 How do you perceive the FDA and the pharmaceutical industry to be relating to clients

who take psychotropic medications? Give

examples.